BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29747482)

  • 1. Effectiveness of oral propranolol for infantile hemangiomas started after 5 months of age.
    Lopez T; Miraglia E; Schiavetti A; Varrasso G; Calvieri S; Giustini S
    G Ital Dermatol Venereol; 2020 Feb; 155(1):115-116. PubMed ID: 29747482
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
    Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
    J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
    Michel JL; Patural H
    Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy of intralesional bleomycin and oral propanolol in management of hemangiomas.
    Thayal PK; Bhandari PS; Sarin YK
    Plast Reconstr Surg; 2012 Apr; 129(4):733e-735e. PubMed ID: 22456397
    [No Abstract]   [Full Text] [Related]  

  • 7. Success in the use of oral propranolol in the treatment of infantile hemangioma in nasal tip - Report of two cases.
    Costa MC; Andrade OGC; Pereira LC; Costa IMC
    An Bras Dermatol; 2020; 95(2):207-209. PubMed ID: 32061465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol treatment for hemangioma of infancy.
    Bonini FK; Bellodi FS; Souza EM
    An Bras Dermatol; 2011; 86(4):763-6. PubMed ID: 21987146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
    Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
    Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel topical nano-propranolol for treatment of infantile hemangiomas.
    Chen ZG; Zheng JW; Yuan ML; Zhang L; Yuan WE
    Nanomedicine; 2015 Jul; 11(5):1109-15. PubMed ID: 25791814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of proporanolol compounding from tablet in infantile hemangiomas.
    Yazici N; Sarialioglu F; Erbay A
    Minerva Pediatr; 2017 Aug; 69(4):369-370. PubMed ID: 28612583
    [No Abstract]   [Full Text] [Related]  

  • 14. Late rebound of infantile hemangioma after cessation of oral propranolol.
    Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
    Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of propranolol therapy in 635 infants with infantile hemangioma.
    Luo Y; Zeng Y; Zhou B; Tang J
    Pediatr Dermatol; 2015; 32(1):151-2. PubMed ID: 24602103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.
    Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA
    Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
    Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
    Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of 2 or 3 mg/kg/day propranolol for infantile hemangioma.
    Goto K; Ozeki M; Yasue S; Endo S; Fukao T
    Pediatr Int; 2020 Jun; 62(6):751-753. PubMed ID: 32490577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.